市場調查報告書
商品編碼
1084343
斑塊切除設備的全球市場趨勢和預測(2022-2028):按驅動器類型、應用、最終用戶和地區Global Atherectomy Devices Market by Device Type, Application, End User and by Geography - Trends and Forecast, 2022 - 2028 |
旋切術是一種去除體內血管動脈硬化的醫療器械。動脈粥樣硬化斑塊切除術是血管成形術的替代療法,廣泛用於治療由於外周動脈疾病引起的動脈狹窄。有四種類型的斑塊切除術:有四種類型:定向旋磨術、旋磨術、激光旋磨術和眼眶旋磨術。
預計心血管疾病 (CVD) 患病率的增加將推動粥樣斑塊切除術的市場增長。根據歐洲心臟網絡 (EHN) 2017 年發表的一篇文章,心血管疾病每年在歐洲造成約 390 萬人死亡,在歐盟造成超過 180 萬人死亡,約佔歐洲所有死亡人數的 45%。佔所有死亡人數的 37%。預計更多創新產品的推出和頻繁的監管批准將推動斑塊切除術設備市場的增長。 2018 年,Avinger Inc. 獲得了下一代 Pantheris Lumivascular Atherectomy System 的 CE 標誌批准,這是一種用於治療外周動脈疾病的圖像引導的旋切術設備。預計新產品採用率的增加將推動全球粥樣斑塊切除設備市場的增長。
本報告調查世界市場,定義和概述市場,分析影響市場增長的各種影響因素、市場規模的變化/預測、各個類別/地區/主要國家的細分以及競爭。它總結了環境、概況大公司等
Atherectomy devices are the medical devices, which are used for removing atherosclerosis from blood vessels within the body. Atherectomy devices are alternative to angioplasty and widely used to treat narrowing in arteries caused by peripheral artery disease. There are four types of atherectomy namely: Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy.
Increasing prevalence of cardiovascular diseases (CVD’s) is expected to drive growth of atherectomy devices market. According to article published in the European Heart Network (EHN) in 2017, CVD causes around 3.9 million deaths in Europe annually and over 1.8 million deaths in the European Union, which accounts for about 45% of all deaths in Europe and 37% of all deaths in the EU. Furthermore launches of innovative products and frequent approval of these devices from regulatory bodies is expected to drive growth of the atherectomy devices market. In 2018, Avinger Inc., received CE Marking approval for next-generation Pantheris Lumivascular atherectomy system, an image-guided atherectomy device for the treatment of Peripheral artery disease. Increasing adoption of novel product is expected to fuel growth of the global atherectomy devices market.
This report provides in-depth analysis of atherectomy devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global atherectomy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global atherectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the atherectomy devices market
Global Atherectomy Devices Market, By Device Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
Global Atherectomy Devices Market, By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
Global Atherectomy Devices Market, By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
Global Atherectomy Devices Market, By Region:
North America
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
U.S.
Canada
Europe
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Application:
Cardiovascular
Neurovascular
Peripheral Vascular
By End User:
Hospital
Ambulatory Surgical Centers
Medical Institutes
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Medtronic plc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Koninklijke Philips N.V.
Cardiovascular Systems, Inc.
Boston Scientific Corporation
Avinger, Inc.
R. Bard, Inc.
Cardinal Health, Inc.
Minnetronix, Inc.
Straub Medical AG
Biotronik
“*” marked represents similar segmentation in other categories in the respective section.